186 related articles for article (PubMed ID: 36734964)
1. Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes.
Ren R; Humphrey AA; Kopczynski C; Gong H
Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):7. PubMed ID: 36734964
[TBL] [Abstract][Full Text] [Related]
2. Relationships between Intraocular Pressure, Effective Filtration Area, and Morphological Changes in the Trabecular Meshwork of Steroid-Induced Ocular Hypertensive Mouse Eyes.
Ren R; Humphrey AA; Swain DL; Gong H
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055036
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
4. Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
Razali N; Agarwal R; Agarwal P; Kapitonova MY; Kannan Kutty M; Smirnov A; Salmah Bakar N; Ismail NM
Eur J Pharmacol; 2015 Feb; 749():73-80. PubMed ID: 25481859
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
[TBL] [Abstract][Full Text] [Related]
6. Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant.
Cho WJ; Lee JM; Bae HW; Kim CY; Seong GJ; Choi W
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1231-1243. PubMed ID: 37930443
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma.
Skaat A; Jasien JV; Ritch R
J Glaucoma; 2016 Sep; 25(9):e807-14. PubMed ID: 27552517
[TBL] [Abstract][Full Text] [Related]
8. Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model.
Kowal TJ; Prosseda PP; Ning K; Wang B; Alvarado J; Sendayen BE; Jabbehdari S; Stamer WD; Hu Y; Sun Y
Transl Vis Sci Technol; 2021 May; 10(6):10. PubMed ID: 34111256
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
[TBL] [Abstract][Full Text] [Related]
10. Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats.
Razali N; Agarwal R; Agarwal P; Tripathy M; Kapitonova MY; Kutty MK; Smirnov A; Khalid Z; Ismail NM
Exp Eye Res; 2016 Feb; 143():9-16. PubMed ID: 26424219
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
12. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
[No Abstract] [Full Text] [Related]
13. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
[TBL] [Abstract][Full Text] [Related]
14. Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells.
Liu Q; Ye Y; Lin X; Yang Y; Wu K; Yu M
Curr Eye Res; 2017 Aug; 42(8):1124-1129. PubMed ID: 28494163
[TBL] [Abstract][Full Text] [Related]
15. Association of trabecular meshwork height with steroid-induced ocular hypertension.
Cho WJ; Kim Y; Kim JD; Kim EW; Bae HW; Kim CY; Choi W
Sci Rep; 2023 Jun; 13(1):9143. PubMed ID: 37277443
[TBL] [Abstract][Full Text] [Related]
16. [Ultrastructural changes of the trabecular meshwork in glucocorticoid induced glaucoma].
Zhao J; Zhang Q
Yan Ke Xue Bao; 2010 Nov; 25(2):119-24. PubMed ID: 21186493
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Ismail NM
Eur J Pharmacol; 2019 May; 850():75-87. PubMed ID: 30716317
[TBL] [Abstract][Full Text] [Related]
19. A laser-induced mouse model with long-term intraocular pressure elevation.
Yun H; Lathrop KL; Yang E; Sun M; Kagemann L; Fu V; Stolz DB; Schuman JS; Du Y
PLoS One; 2014; 9(9):e107446. PubMed ID: 25216052
[TBL] [Abstract][Full Text] [Related]
20. Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.
Gerometta R; Kumar S; Shah S; Alvarez L; Candia O; Danias J
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7903-9. PubMed ID: 24176900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
